Suppression of miR-17 Alleviates Acute Respiratory Distress-associated Lung Fibrosis by Regulating Mfn2

Abstract

Objective

Acute respiratory distress syndrome (ARDS) patients currently have relatively high mortality, which is associated with early lung fibrosis. This study aimed to investigate whether miR-17 suppression could alleviate ARDS-associated lung fibrosis by regulating Mfn2.

Methods

A mouse model of ARDS-related lung fibrosis was constructed via intratracheal instillation of bleomycin. The expression level of miR-17 in lung tissues was detected via quantitative real time polymerase chain reaction (qRT-PCR). In the ARDS mouse model of lung fibrosis, the mitigating effects of miR-17 interference were evaluated via tail vein injection of the miR negative control or the miR-17 antagomir. The pathological changes in the lung tissue were examined via HE staining and Masson’s trichrome staining, and the underlying molecular mechanism was investigated via ELISA, qRT-PCR and Western blotting.

Results

Bleomycin-induced pulmonary fibrosis significantly increased collagen deposition and the levels of hydroxyproline (HYP) and miR-17. Interfering with miR-17 significantly reduced the levels of HYP and miR-17 and upregulated the expression of Mfn2. The intravenous injection of the miR-17 antagomir alleviated lung inflammation and reduced collagen deposition. In addition, interference with miR-17 could upregulate LC3B expression, downregulate p62 expression, and improve mitochondrial structure.

Conclusion

Interfering with miR-17 can improve pulmonary fibrosis in mice by promoting mitochondrial autophagy via Mfn2.

References

[1] Bos LDJ, Ware LB. Acute respiratory distress syndrome: causes, pathophysiology, and phenotypes. Lancet, 2022, 400(10358): 1145-1156

[2] Gragossian A, Siuba MT. Acute Respiratory Distress Syndrome. Emerg Med Clin North Am, 2022, 40(3): 459-472

[3] Marwah V, Choudhary R, Malik V, et al.. Early experience of nintedanib in COVID-19 ARDS-related pulmonary fibrosis: a case series. Adv Respir Med, 2021, 89(6): 589-596

[4] Jayakrishnan B, Kausalya R, Al-Rashdi HA, et al.. Bleomycin and perioperative care: a case report. Sarcoidosis Vasc Diffuse Lung Dis, 2023, 40(3): e2023030

[5] Alzahrani B, Gaballa MMS, Tantawy AA, et al.. Blocking Toll-like receptor 9 attenuates bleomycin-induced pulmonary injury. J Pathol Transl Med, 2022, 56(2): 81-91

[6] Matute-Bello G, Frevert CW, Martin TR. Animal models of acute lung injury. Am J Physiol Lung Cell Mol Physiol, 2008, 295(3): L379-399

[7] O’Brien J, Hayder H, Zayed Y, et al.. Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation. Front Endocrinol (Lausanne), 2018, 9: 402

[8] Lee LK, Medzikovic L, Eghbali M, et al.. The Role of MicroRNAs in Acute Respiratory Distress Syndrome and Sepsis, From Targets to Therapies: A Narrative Review. Anesth Analg, 2020, 131(5): 1471-1484

[9] Guiot J, Henket M, Remacle C, et al.. Systematic review of overlapping microRNA patterns in COVID-19 and idiopathic pulmonary fibrosis. Respir Res, 2023, 24(1): 112

[10] Scheller N, Herold S, Kellner R, et al.. Proviral MicroRNAs Detected in Extracellular Vesicles From Bronchoalveolar Lavage Fluid of Patients With Influenza Virus-Induced Acute Respiratory Distress Syndrome. J Infect Dis, 2019, 219(4): 540-543

[11] Curcio R, Poli G, Fabi C, et al.. Exosomal miR-17, miR-146a-3p, and miR-223-3p Correlate with Radiologic Sequelae in Survivors of COVID-19-Related Acute Respiratory Distress Syndrome. Int J Mol Sci, 2023, 24(17): 13037

[12] Liu Q, Bi Y, Song S, et al.. Exosomal miR-17 from human embryonic stem cells prevents pulmonary fibrosis by targeting thrombospondin-2. Stem Cell Res Ther, 2023, 14(1): 234

[13] Wang X, Liu F, Xu M, et al.. Penehyclidine hydrochloride alleviates lipopolysaccharide induced acute respiratory distress syndrome in cells via regulating autophagy related pathway. Mol Med Rep, 2021, 23(2): 100

[14] Guan R, Yuan L, Li J, et al.. Bone morphogenetic protein 4 inhibits pulmonary fibrosis by modulating cellular senescence and mitophagy in lung fibroblasts. Eur Respir J, 2022, 60(6): 2102307

[15] Wu D, Zhang H, Wu Q, et al.. Sestrin 2 protects against LPS-induced acute lung injury by inducing mitophagy in alveolar macrophages. Life Sci, 2021, 267: 118941

[16] Yan H, Qiu C, Sun W, et al.. Yap regulates gastric cancer survival and migration via SIRT1/Mfn2/mitophagy. Oncol Rep, 2018, 39(4): 1671-1681

[17] Mei M, Sun H, Xu J, et al.. Vanillic acid attenuates H(2)O(2)-induced injury in H9c2 cells by regulating mitophagy via the PINK1/Parkin/Mfn2 signaling pathway. Front Pharmacol, 2022, 13: 976156

[18] Wang J, Wang H, Fang F, et al.. Danggui Buxue Tang Ameliorates Bleomycin-Induced Pulmonary Fibrosis by Suppressing the TLR4/NLRP3 Signaling Pathway in Rats. Evid Based Complement Alternat Med, 2021, 2021: 8030143

[19] Williams GW, Berg NK, Reskallah A, et al.. Acute Respiratory Distress Syndrome. Anesthesiology, 2021, 134(2): 270-282

[20] Zhang W, Lin J, Wang P, et al.. miR-17 down-regulation contributes to erlotinib resistance in non-small cell lung cancer cells. J Drug Target, 2017, 25(2): 125-131

[21] Zhang R, Tan Y, Yong C, et al.. Pirfenidone ameliorates early pulmonary fibrosis in LPS-induced acute respiratory distress syndrome by inhibiting endothelial-to-mesenchymal transition via the Hedgehog signaling pathway. Int Immunopharmacol, 2022, 109: 108805

[22] Wu Q, Zhou Y, Zhou XM. Citrus Alkaline Extract Delayed the Progression of Pulmonary Fibrosis by Inhibiting p38/NF-κB Signaling Pathway-Induced Cell Apoptosis. Evid Based Complement Alternat Med, 2019, 2019: 1528586

[23] Zou JN, Sun L, Wang BR, et al.. The characteristics and evolution of pulmonary fibrosis in COVID-19 patients as assessed by AI-assisted chest HRCT. PLoS One, 2021, 16(3): e0248957

[24] Grifoni E, Valoriani A, Cei F, et al.. Interleukin-6 as prognosticator in patients with COVID-19. J Infect, 2020, 81(3): 452-482

[25] Yamamoto T, Eckes B, Krieg T. Effect of interleukin-10 on the gene expression of type I collagen, fibronectin, and decorin in human skin fibroblasts: differential regulation by transforming growth factor-beta and monocyte chemoattractant protein-1. Biochem Biophys Res Commun, 2001, 281(1): 200-205

[26] Moore KW, O’Garra A, de Waal Malefyt R, et al.. Interleukin-10. Annu Rev Immunol, 1993, 11: 165-190

[27] Shamskhou EA, Kratochvil MJ, Orcholski ME, et al.. Hydrogel-based delivery of IL-10 improves treatment of bleomycin-induced lung fibrosis in mice. Biomaterials, 2019, 203: 52-62

[28] Baker N, Patel J, Khacho M. Linking mitochondrial dynamics, cristae remodeling and supercomplex formation: How mitochondrial structure can regulate bioenergetics. Mitochondrion, 2019, 49: 259-268

[29] Qin W, Zhang YBH, Deng BL, et al.. MiR-17 modulates mitochondrial function of the genioglossus muscle satellite cells through targeting Mfn2 in hypoxia. J Biol Regul Homeost Agents, 2019, 33(3): 753-761

[30] Xu X, Su YL, Shi JY, et al.. MicroRNA-17-5p Promotes Cardiac Hypertrophy by Targeting Mfn2 to Inhibit Autophagy. Cardiovasc Toxicol, 2021, 21(9): 759-771

[31] Liu C, Xiao K, Xie L. Progress in preclinical studies of macrophage autophagy in the regulation of ALI/ARDS. Front Immunol, 2022, 13: 922702

[32] Xie Y, Hu W, Chen X, et al.. Identification and validation of autophagy-related genes in exogenous sepsis-induced acute respiratory distress syndrome. Immun Inflamm Dis, 2022, 10(10): e691